137
Definium Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
146
FY23:
104
FY24:
282
FY25:
419
(positive)
Change from FY21 to FY25
millions USD
FY21:
26.8
FY22:
23.9
FY23:
20.7
FY24:
20.5
FY25:
20.8
Total assets
Change from FY21 to FY25
millions USD
FY21:
164
FY22:
170
FY23:
125
FY24:
302
FY25:
440
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
10.4
FY22:
17.9
FY23:
32.2
FY24:
38.8
FY25:
66.7
(negative)
Change from FY21 to FY25
millions USD
FY21:
1.93
FY22:
1.18
FY23:
14.2
FY24:
21.9
FY25:
41.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
152
FY22:
151
FY23:
78.1
FY24:
241
FY25:
332
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
164
FY22:
170
FY23:
125
FY24:
302
FY25:
440
All amounts in millions USD